HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianpietro Dotti Selected Research

Gianpietro Dotti Research Topics

Disease

126Neoplasms (Cancer)
03/2022 - 07/2002
12Neuroblastoma
11/2020 - 11/2008
10Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 09/2008
10Graft vs Host Disease (Graft-Versus-Host Disease)
04/2016 - 11/2003
9Lymphoma (Lymphomas)
11/2021 - 10/2002
8Melanoma (Melanoma, Malignant)
01/2022 - 09/2008
8Leukemia
01/2016 - 02/2003
7Hodgkin Disease (Hodgkin's Disease)
01/2022 - 10/2007
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 04/2003
7Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2016
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 11/2013
4Multiple Myeloma
03/2019 - 01/2002
4Infections
06/2015 - 10/2002
3Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
3Brain Neoplasms (Brain Tumor)
01/2022 - 12/2011
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2018
3Sarcoma (Soft Tissue Sarcoma)
12/2020 - 05/2015
3Breast Neoplasms (Breast Cancer)
01/2020 - 06/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019 - 01/2019
2Hyperthermia
06/2019 - 06/2015
2Cytokine Release Syndrome
12/2018 - 06/2015
2Glioma (Gliomas)
01/2017 - 02/2016
2Virus Diseases (Viral Diseases)
10/2013 - 08/2009
2Persistent Infection
12/2011 - 07/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2011 - 12/2006
2Testicular Neoplasms (Testicular Cancer)
03/2011 - 09/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2008 - 12/2006
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1Osteosarcoma (Osteogenic Sarcoma)
01/2022

Drug/Important Bio-Agent (IBA)

81Chimeric Antigen ReceptorsIBA
03/2022 - 11/2005
46AntigensIBA
01/2022 - 07/2002
11CytokinesIBA
11/2021 - 10/2007
11Interleukin-15 (Interleukin 15)IBA
01/2021 - 10/2007
9Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 04/2003
8Interleukin-2 (IL2)IBA
06/2014 - 10/2005
7Monoclonal AntibodiesIBA
01/2020 - 03/2005
6VaccinesIBA
01/2019 - 04/2003
5CD40 Ligand (CD40L)IBA
10/2011 - 07/2002
4chondroitin sulfate proteoglycan 4IBA
01/2021 - 01/2015
4Pharmaceutical PreparationsIBA
12/2020 - 11/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018 - 06/2015
4Proteins (Proteins, Gene)FDA Link
05/2015 - 04/2003
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2015
3Ki-1 AntigenIBA
01/2022 - 06/2009
3Immunoglobulins (Immunoglobulin)IBA
11/2021 - 10/2005
3B7-H1 AntigenIBA
01/2021 - 01/2018
3fludarabineIBA
11/2020 - 06/2015
3GD2 gangliosideIBA
10/2020 - 09/2009
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2011
3Immune Checkpoint InhibitorsIBA
01/2020 - 01/2018
3EpitopesIBA
01/2019 - 04/2012
3ChemokinesIBA
01/2018 - 06/2009
3Therapeutic UsesIBA
01/2018 - 08/2010
3AP 1903 reagentIBA
04/2016 - 11/2011
3Caspase 9IBA
04/2016 - 11/2014
3CD19-specific chimeric antigen receptorIBA
01/2016 - 10/2013
3Interleukin-7 (Interleukin 7)IBA
06/2014 - 05/2009
2Interleukin-12 (IL 12)IBA
01/2022 - 01/2018
2InterferonsIBA
01/2022 - 12/2021
2FibrinIBA
10/2021 - 01/2019
2HydrogelsIBA
01/2021 - 10/2020
2vadimezanIBA
01/2021 - 01/2021
2Cancer VaccinesIBA
12/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 01/2018
2InterleukinsIBA
10/2020 - 01/2013
2Panitumumab (Vectibix)FDA Link
01/2020 - 01/2020
2Interferon-gamma (Interferon, gamma)IBA
01/2020 - 11/2005
2Cetuximab (Erbitux)FDA Link
01/2020 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2018
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
06/2019 - 02/2014
2AntibodiesIBA
01/2019 - 10/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2018 - 06/2008
2CD19 AntigensIBA
01/2017 - 05/2011
2human ERBB2 proteinIBA
05/2015 - 06/2007
2Chemokine CCL5IBA
02/2015 - 09/2014
2AutoantigensIBA
01/2015 - 07/2002
2Biological ProductsIBA
09/2014 - 11/2012
2Viral AntigensIBA
10/2013 - 12/2011
2Antiviral Agents (Antivirals)IBA
10/2013 - 04/2010
2LigandsIBA
06/2009 - 03/2005
1VimentinIBA
01/2022
1CCR2 ReceptorsIBA
01/2022
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1tazemetostatIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
12/2021
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
11/2021

Therapy/Procedure

48Immunotherapy
01/2021 - 07/2002
46Therapeutics
03/2022 - 03/2005
6Drug Therapy (Chemotherapy)
12/2019 - 10/2002
5Transplantation
11/2015 - 11/2003
5Stem Cell Transplantation
11/2011 - 08/2007
4Hematopoietic Stem Cell Transplantation
11/2015 - 11/2003
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022 - 12/2021
2Intravenous Infusions
01/2022 - 07/2009
2Intravenous Administration
10/2021 - 01/2021
2Radiotherapy
01/2021 - 10/2014
2Injections
10/2020 - 10/2014
1Transjugular Intrahepatic Portasystemic Shunt
03/2022